BIOGEN INC. (BIIB) Revenue 2016–2025
BIOGEN INC. (BIIB) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$9.9BFY2025 · since FY2016: $11.4B → $9.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.9B | +2.2% |
| FY2024 | $9.7B | -1.6% |
| FY2023 | $9.8B | -3.3% |
| FY2022 | $10.2B | -7.4% |
| FY2021 | $11.0B | -18.3% |
| FY2020 | $13.4B | -6.5% |
| FY2019 | $14.4B | +6.9% |
| FY2018 | $13.5B | +9.6% |
| FY2017 | $12.3B | +7.2% |
| FY2016 | $11.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB Net incomeBIIB Net marginBIIB Gross profitBIIB Gross marginBIIB Operating incomeBIIB Operating marginBIIB Operating cash flowBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Stock buybacksBIIB Dividends paidBIIB Total assetsBIIB Total liabilitiesBIIB Shareholders’ equityBIIB overview →